Tel: +251 11 551 77 00 — communications@africacdc.org

Internal Directive on Sexual Exploitation and Abuse and Sexual Harrassment

Download
  • Version
  • Download 905
  • File Size 236.13 KB
  • File Count 1
  • Create Date 25 January 2024
  • Last Updated 26 January 2024

Internal Directive on Sexual Exploitation and Abuse and Sexual Harrassment

Introduction
1. In executing its mandate, Africa CDC complies with the African Union’s policies for the prevention, reporting and response to misconduct. This includes sexual misconduct in the form of sexual exploitation and abuse (SEA) and sexual harassment (SH). Africa CDC also honours various continental instruments promoting human dignity including the African Charter on Human and Peoples’ Rights1, the African Union’s Solemn Declaration on Gender Equality in Africa2, and the African Charter on Rights and Welfare of the Child3. Accordingly, Africa CDC has “zero tolerance” for sexual misconduct, will refer for investigation any reported instances, support sanctioning where this misconduct has been established, and support assistance and redress to victims in accordance with African Union policies.

2. The objective of this Internal Directive is to support Africa CDC’s commitment to the prevention of SEA and SH in its operations, programs and projects; and to taking appropriate measures in response to observed or alleged SEA and SH.

Attached Files

FileAction
Internal Directive on Sexual Exploitation and Abuse and Sexual HarrassmentDownload

This slide deck, presented at the Developing Countries Vaccine Manufacturers Network International Annual General Meeting in October 2024, describes updated results from a study to assess the current and planned state of vaccine manufacturing in Africa and provides insights into what’s needed to develop a robust and sustainable vaccine manufacturing ecosystem.

We surveyed African vaccine manufacturers to better understand their current manufacturing capacity and capabilities, the progress they’ve made since 2023, and their future outlooks. This information can help stakeholders and funders better coordinate and prioritize actions to build a successful African vaccine manufacturing ecosystem.

Corporate author(s): Africa Centres for Disease Control and Prevention (Africa CDC); Clinton Health Access Initiative (CHAI); PATH

Publication date: October 2024

Download Files
FileAction
African Vaccine Manufacturing Mapping | Supply and Demand LandscapeDownload
Download

"]

Related Content

Follow Us
Twitter Linkedin Facebook-f Youtube Flickr Instagram